PT1909792E - Derivados substituídos da piperidina como antagonistas do receptor sst1 da somatostatina - Google Patents
Derivados substituídos da piperidina como antagonistas do receptor sst1 da somatostatina Download PDFInfo
- Publication number
- PT1909792E PT1909792E PT06762563T PT06762563T PT1909792E PT 1909792 E PT1909792 E PT 1909792E PT 06762563 T PT06762563 T PT 06762563T PT 06762563 T PT06762563 T PT 06762563T PT 1909792 E PT1909792 E PT 1909792E
- Authority
- PT
- Portugal
- Prior art keywords
- receptor antagonists
- substituted piperidine
- piperidine derivatives
- sst1 receptor
- somatostatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0514615.4A GB0514615D0 (en) | 2005-07-15 | 2005-07-15 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1909792E true PT1909792E (pt) | 2009-12-09 |
Family
ID=34897328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT06762563T PT1909792E (pt) | 2005-07-15 | 2006-07-13 | Derivados substituídos da piperidina como antagonistas do receptor sst1 da somatostatina |
Country Status (17)
Country | Link |
---|---|
US (1) | US7754719B2 (pt) |
EP (1) | EP1909792B1 (pt) |
JP (1) | JP2009501180A (pt) |
KR (1) | KR20080025731A (pt) |
CN (1) | CN101222924A (pt) |
AT (1) | ATE441415T1 (pt) |
AU (1) | AU2006272049A1 (pt) |
BR (1) | BRPI0612994A2 (pt) |
CA (1) | CA2615236A1 (pt) |
DE (1) | DE602006008957D1 (pt) |
ES (1) | ES2333165T3 (pt) |
GB (1) | GB0514615D0 (pt) |
MX (1) | MX2008000709A (pt) |
PL (1) | PL1909792T3 (pt) |
PT (1) | PT1909792E (pt) |
RU (1) | RU2008105362A (pt) |
WO (1) | WO2007009662A1 (pt) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149817A (en) | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
JP2001502712A (ja) * | 1996-10-31 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト |
EP1086947A1 (en) * | 1999-09-01 | 2001-03-28 | Pfizer Products Inc. | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
US7115741B2 (en) | 2001-09-06 | 2006-10-03 | Levy Daniel E | 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds |
GB0127008D0 (en) | 2001-11-09 | 2002-01-02 | Novartis Ag | Organic compounds |
WO2004011430A1 (ja) | 2002-07-25 | 2004-02-05 | Yamanouchi Pharmaceutical Co., Ltd. | ナトリウムチャネル阻害剤 |
-
2005
- 2005-07-15 GB GBGB0514615.4A patent/GB0514615D0/en not_active Ceased
-
2006
- 2006-07-13 BR BRPI0612994-3A patent/BRPI0612994A2/pt not_active IP Right Cessation
- 2006-07-13 PL PL06762563T patent/PL1909792T3/pl unknown
- 2006-07-13 CN CNA2006800259166A patent/CN101222924A/zh active Pending
- 2006-07-13 CA CA002615236A patent/CA2615236A1/en not_active Abandoned
- 2006-07-13 EP EP06762563A patent/EP1909792B1/en active Active
- 2006-07-13 PT PT06762563T patent/PT1909792E/pt unknown
- 2006-07-13 DE DE602006008957T patent/DE602006008957D1/de active Active
- 2006-07-13 AU AU2006272049A patent/AU2006272049A1/en not_active Abandoned
- 2006-07-13 MX MX2008000709A patent/MX2008000709A/es not_active Application Discontinuation
- 2006-07-13 ES ES06762563T patent/ES2333165T3/es active Active
- 2006-07-13 KR KR1020087001023A patent/KR20080025731A/ko not_active Application Discontinuation
- 2006-07-13 US US11/995,725 patent/US7754719B2/en not_active Expired - Fee Related
- 2006-07-13 JP JP2008520800A patent/JP2009501180A/ja active Pending
- 2006-07-13 RU RU2008105362/04A patent/RU2008105362A/ru not_active Application Discontinuation
- 2006-07-13 AT AT06762563T patent/ATE441415T1/de active
- 2006-07-13 WO PCT/EP2006/006867 patent/WO2007009662A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20080255142A1 (en) | 2008-10-16 |
EP1909792A1 (en) | 2008-04-16 |
CA2615236A1 (en) | 2007-01-25 |
EP1909792B1 (en) | 2009-09-02 |
ES2333165T3 (es) | 2010-02-17 |
WO2007009662A1 (en) | 2007-01-25 |
RU2008105362A (ru) | 2009-08-20 |
ATE441415T1 (de) | 2009-09-15 |
AU2006272049A1 (en) | 2007-01-25 |
CN101222924A (zh) | 2008-07-16 |
DE602006008957D1 (de) | 2009-10-15 |
BRPI0612994A2 (pt) | 2010-12-14 |
GB0514615D0 (en) | 2005-08-24 |
JP2009501180A (ja) | 2009-01-15 |
KR20080025731A (ko) | 2008-03-21 |
PL1909792T3 (pl) | 2010-02-26 |
MX2008000709A (es) | 2008-03-18 |
US7754719B2 (en) | 2010-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
TW200800956A (en) | 2-Aminopyrimidine derivatives | |
TNSN08269A1 (en) | Derives de pyrimidine | |
TN2010000101A1 (en) | Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives | |
WO2008020405A3 (en) | Azetidine compounds as orexin receptor antagonists | |
ATE524466T1 (de) | 3-azabicycloä3.3.0üoktanverbindungen | |
MX2009009774A (es) | Derivados de quinolina como fungicidas. | |
MXPA06012595A (es) | Analogos de amino-tetrazoles y metodos de uso. | |
TW200600494A (en) | Bisphenyl compounds useful as vitamin d3 receptor agonists | |
TW200728277A (en) | Bicyclic derivatives as P38 inhibitors | |
WO2007056091A3 (en) | 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof | |
TW200637837A (en) | Fungicides | |
DK1833791T3 (da) | 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
MXPA06000921A (es) | Derivados de benzamidazoles como inhibidores de mek. | |
TW200700396A (en) | Pyrazine-2-carboxamide derivatives as mglur5 antagonists | |
MX2009010552A (es) | Antagonistas de receptor de opioide periferico y usos de los mismos. | |
TW200619206A (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
UA101963C2 (en) | 4-amino-pyrimidine derivatives | |
DK1954668T3 (da) | Homo- og heterocykliske forbindelser, der er egnede som CETP-inhibitorer | |
TW200700358A (en) | Organic compounds | |
TN2009000040A1 (en) | 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists | |
EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
MXPA05013149A (es) | Derivados de imidazol como antagonistas del receptor de glutamato. |